FOSCAN Solution for injection Ref.[9097] Active ingredients: Temoporfin

Source: European Medicines Agency (EU)  Revision Year: 2016  Publisher: biolitec Pharma Ltd., Otto-Schott-Str. 15, 07745, Jena, Germany

Product name and form

Foscan 1 mg/ml solution for injection.

Pharmaceutical Form

Solution for injection.

Dark purple solution.

Qualitative and quantitative composition

Each ml contains 1 mg of temoporfin.

Excipients with known effect: Each ml contains 376 mg of ethanol anhydrous and 560 mg of propylene glycol.

For the full list of excipients, see section 6.1

Active Ingredient Description
Temoporfin

Temoporfin is a photosensitising agent used in the photodynamic therapy of tumours.

List of Excipients

Ethanol, anhydrous (E1510)
Propylene glycol (E1520)

Pack sizes and marketing

Type I amber glass vials with a bromobutyl elastomer stopper and aluminium seal containing either 1 ml or 3 ml or 6 ml of solution for injection.

Each pack contains 1 vial and a filter with Luer lock connections for syringe and cannula. Not all pack sizes may be marketed.

Marketing authorization holder

biolitec Pharma Ltd., Otto-Schott-Str. 15, 07745, Jena, Germany

Marketing authorization dates and numbers

EU/1/01/197/003
EU/1/01/197/004
EU/1/01/197/005

Date of first authorisation: 24 October 2001

Date of latest renewal: 22 September 2011

Drugs

Drug Countries
FOSCAN Austria, Estonia, France, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, United Kingdom

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.